Laparoscopic Sleeve Gastrectomy versus Laparoscopic Roux-en-Y Gastric Bypass in Management of Morbid Obesity: Midterm Results in a Single Center

Year 2025, Volume: 32 Issue: 3, 192 - 197, 09.09.2025

Oktay Karaköse , Servet Karagül , Serdar Şenol , Huseyin Eken , Ahmet Akbaş

Abstract

Objective: Laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) are widely used surgical procedures for morbid obesity. The objective of the study was to present the mid-term results of our first LSG and LRYGB cases.
Material and Method: We retrospectively reviewed LSG and LRYGB patients treated at Samsun Training and Research Hospital, Turkey, within the period from January 2016 to December 2020. The demographic data of patients, comprising age, gender, body mass index (BMI), obesity-related diseases, and medications, were registered. The percentage total weight loss (%TWL), percentage excess weight loss (%EWL), and postoperative BMI were evaluated, and the results of both groups were compared.
Results: The LSG and LRYGB groups comprised 19 and 43 patients, respectively. Of these, 50 were female and 12 were male. The average age in the LSG group was 30.89 ± 7.56 years, whereas in the LRYGB group it was 42.56 ± 12.18 years (p < 0.05). The mean %EWL was 72.35 ± 35.24 and 76.08 ± 22.84, and the mean %TWL was 30.46 ± 13.37 and 34.70 ± 11.31, respectively (p  0.05). BMI was 31.84 ± 8.76 in the LSG group and 30.14 ± 5.05 in the LRYGB group (p  0.05). B12 and Fe deficiency were observed in LRYGB cases, with a significant difference found between the groups. The mean follow-up was 50.47 ± 10.93 months in the LSG group and 52.21 ± 11.58 months in the LRYGB group (p  0.05).
Conclusion: LSG and LRYGB are two bariatric surgical procedures that are safe and effective with adequate weight loss in the medium term. Monitoring for B12 and Fe deficiency is important in patients undergoing LRYGB.

Keywords

morbid obesity , Roux-n-Y gastric bypass , sleeve gastrectomy

Ethical Statement

Approval was obtained from the Samsun Training and Research Hospital Ethics Committee (No: GOKAEK 2024/4/13). The study was conducted in accordance with the principles set forth in the Declaration of Helsinki.

References

• 1. Hemmingsson E, Ekblom Ö, Kallings LV, et al. Prevalence and time trends of overweight, obesity, and severe obesity in 447,925 Swedish adults, 1995–2017. Scand J Public Health 2021;49(4):377–83. doi:10.1177/1403494820914802
• 2. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief 2020;(360):1–8.
• 3. Askari M, Heshmati J, Shahinfar H, Shirani F, Sharbafi MH, Amini M, et al. Ultra-processed food and the risk of overweight and obesity: A systematic review and meta-analysis of observational studies. Int J Obes (Lond) 2020;44(10):2080–91. doi:10.1038/s41366-020-0609-7
• 4. Juul F, Martinez Steele E, Parekh N, Monteiro CA, Chang VW. Ultra-processed food consumption and excess weight among US adults. Br J Nutr 2018;120(1):90–100. doi:10.1017/S0007114517002022
• 5. Silveira EA, Mendonça CR, Delpino FM, et al. Sedentary behavior, physical inactivity, abdominal obesity, and obesity in adults and older adults: A systematic review and meta-analysis. Clin Nutr ESPEN 2022;50:63–73. doi: 0.1016/j.clnesp.2022.05.005
• 6. Day K, Alfonzo M, Chen Y, et al. Overweight, obesity, and inactivity, and urban design in rapidly growing Chinese cities. Health Place 2013;21:29–38. doi: 0.1016/j.healthplace.2013.01.007
• 7. Vitiello A, Angrisani L, Santonicola A, Panico G, De Sena G. Bariatric surgery versus lifestyle intervention in Class I obesity: 7–10 year results of a retrospective study. World J Surg 2019;43(3):758–62. doi:10.1007/s00268-018-4845-1
• 8. Hofsø D, Nordstrand N, Johnson LK, et al. Obesity related cardiovascular risk factors after weight loss: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010;163(5):735–45. doi:10.1530/EJE-10-0055
• 9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292(14):1724–37. doi:10.1001/jama.292.14.1724
• 10. Edholm D, Svensson F, Näslund I, et al. Long-term results 11 years after primary gastric bypass in 384 patients. Surg Obes Relat Dis 2013;9(5):708–13. doi: 0.1016/j.soard.2013.06.009
• 11. Smith CD, Herkes SB, Behrns KE, et al. Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg 1993;218(1):91–6. doi:10.1097/00000658-199307000-00014
• 12. Sargsyan N, Das B, Robb H, et al. Outcomes of one anastomosis gastric bypass conversion to Roux-en-Y gastric bypass for severe obesity: A systematic review and meta-analysis. Obes Surg 2024;34(3):976–84. doi:10.1007/s11695-023-06954-2
• 13. Carandina S, Soprani A, Sista F, et al. Conversion of one anastomosis gastric bypass (OAGB) to Roux-en-Y gastric bypass (RYGB) for gastroesophageal reflux disease (GERD): Who is more at risk? A multicenter study. Surg Endosc 2024;38(3):1163–69. doi:10.1007/s00464-023-10937-8
• 14. Dayan D, Kanani F, Bendayan A, et al. The effect of revisional one anastomosis gastric bypass after sleeve gastrectomy on gastroesophageal reflux disease, compared with revisional Roux-en-Y gastric bypass: Symptoms and quality of life outcomes. Obes Surg 2023;33(7):2125–31. doi:10.1007/s11695-022-06335-5
• 15. Delko T, Kraljević M, Lazaridis II, et al. Laparoscopic Roux-Y gastric bypass versus laparoscopic one anastomosis gastric bypass for obesity: Clinical & metabolic results of a prospective randomized controlled trial. Surg Endosc 2024;38(7):3875–86. doi:10.1007/s00464-023-11117-2
• 16. Salte OBK, Olbers T, Risstad H, et al. Ten-year outcomes following Roux-en-Y gastric bypass vs duodenal switch for high body mass index: A randomized clinical trial. JAMA Netw Open 2024;7(6):e2414340. doi:10.1001/jamanetworkopen.2024.14340
• 17. Jain M, Tantia O, Goyal G, et al. LSG vs OAGB: 7-year follow-up data of a randomised control trial and comparative outcome based on BAROS score. Obes Surg 2024;34(4):1295–305. doi:10.1007/s11695-024-06123-5
• 18. Chalmers KA, Cousins SE, Blazeby JM. By Band Sleeve Trial Management Group. Randomized controlled trials comparing gastric bypass, gastric band, and sleeve gastrectomy: A systematic review examining validity and applicability to wider clinical practice. Obes Rev 2024;25(5):e13718. doi:10.1111/obr.13718
• 19. Nishizaki D, Ganeko R, Hoshino N, et al. Roux-en-Y versus Billroth I reconstruction after distal gastrectomy for gastric cancer. Cochrane Database Syst Rev 2021;9(9):CD012998. doi:10.1002/14651858.CD012998.pub2
• 20. Cai Z, Zhou Y, Wang C, et al. Optimal reconstruction methods after distal gastrectomy for gastric cancer: A systematic review and network meta-analysis. Medicine (Baltimore) 2018;97(20):e10823. doi:10.1097/MD.00000000000010823
• 21. Hong J, Wang SY, Hao HK. A comparative study of double tract reconstruction and Roux-en-Y after gastrectomy for gastric cancer. Surg Laparosc Endosc Percutan Tech 2019;29(2):82–9. doi:10.1097/SLE.0000000000000619
• 22. Raza MM, Njideaka Kevin T, Polo J, et al. Long-term outcomes of bariatric surgery: A systematic review. Cureus 2023;15(5):e39638. doi:10.7759/cureus 39638
• 23. O’Brien PE, Hindle A, Brennan L, et al. Long-term outcomes after bariatric surgery: A systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single centre review of 20-year outcomes after adjustable gastric banding. Obes Surg 2019;29(1):3–14. doi:10.1007/s11695-018-3525-y
• 24. Raaijmakers LC, Pouwels S, Thomassen SE, et al. Quality of life and bariatric surgery: A systematic review of short and long-term results and comparison with community norms. Eur J Clin Nutr 2017;71(4):441–9. doi:10.1038/ejcn.2016.259
• 25. Bastos ELS, Salgado W Jr, Dantas ACB, et al. Medium and long-term weight loss after revisional bariatric surgery: A systematic review and meta-analysis. Obes Surg 2024;34(5):1917–28. doi:10.1007/s11695-024-05941-8
• 26. Singh B, Saikaustubh Y, Singla V, et al. One anastomosis gastric bypass (OAGB) vs Roux-en-Y gastric bypass (RYGB) for remission of T2DM in patients with morbid obesity: A randomized controlled trial. Obes Surg 2023;33(4):1218–27. doi:10.1007/s11695-022-06421-3
• 27. Level L, Rojas A, Piñango S, Luque R, Fernández Calle P, Mira J, et al. One anastomosis gastric bypass vs Roux en Y gastric bypass: A 5 year follow up prospective randomized trial. Langenbecks Arch Surg 2021;406(1):171–9. doi:10.1007/s00423-020-02026-4
• 28. Biter LU, ’t Hart JW, Noordman BJ, et al. Long term effect of sleeve gastrectomy vs Roux en Y gastric bypass in people living with severe obesity: A phase III multicentre randomised controlled trial (SleeveBypass). Lancet Reg Health Eur 2024;38:100836. doi:10.1016/j.lanepe.2024.100836
• 29. Kachornvitaya P, Sornphiphatphong S, Chaivanijchaya K, et al. Comparison of long term outcomes after laparoscopic sleeve gastrectomy and laparoscopic Roux en Y gastric bypass for morbid obesity. Asian J Surg 2024;28:S1015 9584(24)01269 7.
• 30. Aguirre Talledo J, Caballero Alvarado J, De la Cruz Davila M, et al. Roux en Y gastric bypass vs vertical sleeve gastrectomy in the remission of type 2 diabetes mellitus: A systematic review and meta analysis. Pol Przegl Chir 2024;96(3):69–82.